Outcomes of bilateral implantation of phakic IOLs

Article

Dr Antonio Toso discusses his recent study of 8 patients who received bilateral implantations of the Acrysof Cachet Phakic IOLs. Dr Toso and Dr Morselli described the visual outcomes and the aberrometry of this study at the 2010 ESCRS meeting in Paris.

It has been previously reported by Drs Marco and Giuseppe Lombardo that analysis of wavefront aberrations can be used in determining the optical quality and visual performance of the eye.1 On reading this study Dr Antonio Toso of the St Bassiano Hospital in Bassano del Grappa, Italy, realised that young, highly myopic patients suffer from poor distance vision, mainly in mesopic conditions. This is a result of positive spherical aberration, which becomes the dominant high order aberration in degrading optical quality when the pupils dilate. Dr Toso decided that he would like to understand whether the AcrySof Cachet phakic IOL (pIOL) from Alcon Laboratories would be able to provide a better quality of distance vision.

In collaboration with Dr Simonetta Morselli, Dr Toso examined the visual outcomes and aberrometry in a group of eight patients who had undergone bilateral implantation with the Acrysof Cachet pIOL. The results of this study were presented at the 2010 ESCRS Meeting held in Paris.

Lens selection

Dr Toso revealed that the lens was very easy to implant and he explained: "The design and softness of the haptics do not cause pupil ovalisation and conform to the shape of the angle very well." Additionally, he found it beneficial that the lens has been made of the same soft and flexible hydrophobic acrylic material as the other AcrySof IOLs. "Besides all of this, the water-tight corneal incision (no more than 2.6 mm) and not being required to perform peripheral iridotomy, convinced me of the advantages of this lens," he continued.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
Related Content
© 2025 MJH Life Sciences

All rights reserved.